Michael Ramharter

Research interests

Publications

• A time-resolved proteomic and prognostic map of COVID-19

  Cell Systems · 2021 · 10.1016/j.cels.2021.05.005

• Germany COVID-19 Snapshot MOnitoring (COSMO Germany): Monitoring knowledge, risk perceptions, preventive behaviours, and public trust in the current coronavirus outbreak in Germany

  · 2020 · 10.23668/psycharchives.2776

• Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers

  Clinical Microbiology Reviews · 2020 · 10.1128/cmr.00104-19

• Diagnostic Techniques of Soil-Transmitted Helminths: Impact on Control Measures

  Tropical Medicine and Infectious Disease · 2020 · 10.3390/tropicalmed5020093

• Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis

  International Journal of Infectious Diseases · 2019 · 10.1016/j.ijid.2019.07.015

• Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna

  Clinical Infectious Diseases · 2018 · 10.1093/cid/ciy279

• A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

  BMC Medicine · 2017 · 10.1186/s12916-017-0940-3

• Severe malaria in Europe: an 8-year multi-centre observational study

  Malaria Journal · 2017 · 10.1186/s12936-016-1673-z

• A systematic review of the clinical presentation, treatment and relapse characteristics of human Plasmodium ovale malaria

  Malaria Journal · 2017 · 10.1186/s12936-017-1759-2

• Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing

  Malaria Journal · 2017 · 10.1186/s12936-017-2044-0

• A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1513137

• Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study

  BMJ Open · 2016 · 10.1136/bmjopen-2016-011783

• Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

  New England Journal of Medicine · 2015 · 10.1056/nejmoa1502924

• Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial

  PLoS Medicine · 2014 · 10.1371/journal.pmed.1001733

• Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence

  International Journal of Infectious Diseases · 2014 · 10.1016/j.ijid.2014.09.007

• Randomized, Controlled, Assessor-Blind Clinical Trial To Assess the Efficacy of Single- versus Repeated-Dose Albendazole To Treat Ascaris lumbricoides, Trichuris trichiura, and Hookworm Infection

  Antimicrobial Agents and Chemotherapy · 2014 · 10.1128/aac.01317-13

• Management of imported malaria in Europe

  Malaria Journal · 2012 · 10.1186/1475-2875-11-328

• Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections

  Antimicrobial Agents and Chemotherapy · 2012 · 10.1128/aac.05359-11

• Epidemiology of parasitic co-infections during pregnancy in Lambaréné, Gabon

  Tropical Medicine & International Health · 2010 · 10.1111/j.1365-3156.2010.02598.x

• Adolescence As Risk Factor for Adverse Pregnancy Outcome in Central Africa – A Cross-Sectional Study

  PLoS ONE · 2010 · 10.1371/journal.pone.0014367

• Fixed‐Dose Pyronaridine‐Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon

  The Journal of Infectious Diseases · 2008 · 10.1086/591096

• MICROSCOPIC AND SUB-MICROSCOPIC PLASMODIUM FALCIPARUM INFECTION, BUT NOT INFLAMMATION CAUSED BY INFECTION, IS ASSOCIATED WITH LOW BIRTH WEIGHT

  American Journal of Tropical Medicine and Hygiene · 2006 · 10.4269/ajtmh.2006.75.798

• Safety and Enhanced Immunogenicity of a Hepatitis B Core ParticlePlasmodium falciparumMalaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial

  Infection and Immunity · 2005 · 10.1128/iai.73.6.3587-3597.2005

• Fosmidomycin‐Clindamycin for the Treatment ofPlasmodium falciparumMalaria

  The Journal of Infectious Diseases · 2004 · 10.1086/424603

Current projects

No projects listed.